Skip to main content
Fig. 4 | BMC Pharmacology and Toxicology

Fig. 4

From: Real-world research on beta-blocker usage trends in China and safety exploration based on the FDA Adverse Event Reporting System (FAERS)

Fig. 4

This heatmap illustrates the ADRs associated with three categories of beta-blockers. Each row represents a different adverse event term (PT), while each column corresponds to a specific beta-blocker agent. The color intensity reflects both the ROR and the number of reports for each ADR, providing a visual comparison of the safety profiles of these beta-blockers

Back to article page

BMC Pharmacology and Toxicology

ISSN: 2050-6511

Contact us